Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Engineered cartilage grafts improve surgery for narrowed child airways

A study led by researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a new method of using decellularized cartilage with patient-specific cells to help enlarge the pediatric airways narrowed as a result of severe subglottic stenosis.

17 Jun 2026

FutureNeuro launches proteomics study to personalize psychosis treatment

FutureNeuro, the Research Ireland Centre for Translational Brain Science hosted by RCSI University of Medicine and Health Sciences, has launched a new proteomics study aimed at identifying biological markers that could support more personalized treatment for people experiencing first‑episode psychosis.

16 Jun 2026

Hormone cycles dictate how the brain absorbs neuroprotective drugs

Consider what we ask of a clinical trial. We gather people who differ in nearly every way that matters, we give them the same drug at the same dose, and then we average the result and call the average truth.

16 Jun 2026

New USC clinical trial explores psilocybin for mental health

Researchers at the Keck School of Medicine of USC, the Brain and Creativity Institute at the USC Dornsife College of Letters, Arts and Sciences, and the USC Norris Comprehensive Cancer Center have launched the University of Southern California's first study of psychedelic therapy.

16 Jun 2026

Social media overuse is linked to more self-reported memory problems in young adults

Problematic social media use was associated with more frequent self-reported everyday memory failures in 943 Spanish young adults aged 18 to 35. Everyday memory failures statistically accounted for much of the link between problematic social media use and both prospective and retrospective memory lapses.

15 Jun 2026

New EHR-based marker flags transplant patients at high risk for organ rejection

A new multicenter study led by researchers at the Icahn School of Medicine at Mount Sinai suggests that a novel electronic health record-based marker can help clinicians identify transplant patients at high risk for organ rejection due to not taking their medications as prescribed-and intervene before the rejection happens.

15 Jun 2026

Non-hormonal menopausal medication improves mood and hot flashes

The first real-world study of the FDA-approved non-hormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026

Parkinson's drug may ease anhedonia in treatment-resistant depression

For many people who suffer from depression, the condition is not just about feeling down, but also about a loss of motivation and difficulty finding pleasure in activities they used to enjoy.

12 Jun 2026

Cerebellar structural changes influence social behavior in autism

Researchers at Kanazawa University have identified a previously unrecognized mechanism by which structural changes in the cerebellum influence social behavior.

12 Jun 2026

ChatGPT fills gaps like a confabulator, not a hallucinating mind

A Perspective article argues that large language model errors more closely resemble confabulations, while speech recognition errors, such as unsupported Whisper transcriptions, are functionally closer to hallucinations. The authors stress that these parallels are behavioral and provisional, not evidence of shared consciousness, and suggest that psychiatric concepts could help improve AI reliability.

11 Jun 2026

Genetic study links liver enzyme to compulsive cocaine addiction

Researchers at the University of California San Diego have completed a massive genetic study that identifies key biological drivers of cocaine addiction, uncovering a potential new target for treatment that resides in the liver rather than the brain.

11 Jun 2026

Teenage risk-taking linked to lower baseline dopamine levels

Teenage risk-taking, such as experimentation with alcohol, cannabis, nicotine and other substances, may reflect a compensatory response to lower baseline dopamine, the brain chemical for reward activity, suggests a new University of Pittsburgh School of Medicine study, published today in Nature Communications.

11 Jun 2026

Social anxiety disorder now affects one in seven Canadian adults

A new Canadian study has found that social anxiety disorder (SAD) now affects nearly 1 in 7 adults - a 71% increase since 2002 - making it one of the most common mental health challenges in the country.

10 Jun 2026

Fluctuating hormones during menopause reshape brain activity patterns

Research at the Robert Larner, M.D. College of Medicine at the University of Vermont reveals how menopause, once a taboo topic, affects brain function, reinforcing the idea that the menopause transition is not only a reproductive milestone, but also a critical neurological phase.

9 Jun 2026

Large study uncovers brain network differences in bipolar disorder

New research from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has discovered subtle but widespread differences in the brain's communication networks in people with bipolar disorder, offering new insight into how illness severity and treatment may relate to brain wiring.

9 Jun 2026

New study identifies brain circuit behind TMS’s antidepressant effects

A circuit that runs from the prefrontal cortex near the front of the brain to a deeper brain structure called the insular cortex appears to mediate the antidepressant effects of a newer form of transcranial magnetic stimulation (TMS), according to a study led by Weill Cornell Medicine investigators.

9 Jun 2026

Massive genetic study uncovers new insights into anxiety risk

A study led by researchers at King’s College London and QIMR Berghofer medical research institute analysed genetic data on anxiety symptoms in 693,869 people of European ancestry, revealing new insight into the genetic pathways involved in the condition.

9 Jun 2026

Antidepressants trigger opposite reactions in different groups of serotonin-producing brain cells

A new study has uncovered how antidepressants affect different groups of serotonin-producing brain cells in opposite ways, offering new insights into why selective serotonin reuptake inhibitors (SSRIs) can cause unpleasant side effects at the start of treatment but lead to symptom relief over time.

8 Jun 2026

Early outdoor play reduces future mental health risks in children

Children who spend more time playing outdoors between the ages of two and four may be less likely to develop emotional and behavioural difficulties later in childhood.

8 Jun 2026

Weight loss drugs linked to lower risk of alcohol, opioid, nicotine and cocaine use disorders

A new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders.

8 Jun 2026